Reportlinker finds all market research
reports published by official sources!

Investor presentation: Pathology for Year 2011

  • This 27-page company report was published in March 2011.
... as well as 435 Pathology industry reports, company profiles and country guides published by official sources (government, embassies, trade unions...).

Privacy Policy by TRUSTe

We value your privacy and will never rent or sell your email address. Privacy Policy by TRUSTe

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Talk to Sam

(866) 682 9815

Share

Follow

Add to circles RSS Feed

Pathology Industry : Latest Downloads

Company Report: Pathology for Year 2013

Company Report: Pathology for Year 2013

  • Company report
  • April 2013
  • 35 pages

... Of glycemic control in adults and children with diabetes mellitus. Humalog S mechanism of action includes regulation of glucose metabolism, lowering of blood glucose by stimulating peripheral glucose uptake ...

Company Report: Pathology for Year 2013

Company Report: Pathology for Year 2013

  • Company report
  • April 2013
  • 182 pages

... Initially. 9 learning disability - 14 dates to be commenced 25 th june 13 clinical staff / any staff group. Other Adhoc honour based violence - adhoc managed at divisional level Needs led band ...

Company Report: Pathology for Year 2013

Company Report: Pathology for Year 2013

  • Company report
  • March 2013
  • 16 pages

... D collaboration. Various cannabinoids (including cbd, cbdv, cbc, cbg, thca, thcv, cbn) as single agents and combinations for other cns (anti-psychotic, anti-depressant and anxiolytic) and anti-cancer indication ...

Company Report: Pathology For Year 2013

3 months ago

Accountable - Company Report For Year 2013

3 months ago

Company Report: Breast Cancer For Year 2013

3 months ago

Company Report: Pathology For Year 2013

3 months ago

Company Report: Pathology For Year 2013

3 months ago

Biomarin Pharmaceutical Inc. - Company Report ...

3 months ago

Company Report: Pathology For Year 2013

4 months ago

Market Figures

Pharmaceutical Key Market Figures
2 months ago
The Mexican Pharmaceutical Business : Key Market Figure...
2 months ago
Pharmaceutical Key Market Figures In The United States
7 months ago
U.s. Pharmaceutical Sector : Key Market Figures
7 months ago
Pharmaceutical Key Market Figures In Germany, South Ko...
8 months ago
More »

Trade Statistics

The European Pharmaceutical Industry : Production And T...
11 months ago

Technology Trends

Cardiovascular Disease Sector Trends (cardiovascular Di...
2 months ago
Global Pharmaceutical Sector Trends
4 months ago
Pharmaceutical Industry Trends In The United States An...
10 months ago
Pharmaceutical Industry Trends
11 months ago
Mental Disorder Sector Trends In The United States
12 months ago

More Reports:

Pathology in Australia (47)
Pathology in Brazil (6)
Pathology in Canada (45)
Pathology in China (14)
Pathology in Denmark (7)
Pathology in Finland (5)
Pathology in France (12)
Pathology in Germany (14)
Pathology in Greece (5)

Related Market Segments :

Cancer
Cardiovascular Disease
Acute Coronary Syndrome
Stroke
Atrial Fibrillation

Pathology Industry : Latest Reports

Pathology in United States: Breast Cancer - Pipeline Review, H1 2012

Pathology in United States: Breast Cancer - Pipeline Review, H1 2012

  • $ 2 500
  • Company report
  • April 2013
  • by Global Markets Direct

This report provides information on the therapeutic development for Breast Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

World Pathology: Deep Vein Thrombosis (DVT) ? Pipeline Review, H1 2012

World Pathology: Deep Vein Thrombosis (DVT) ? Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • March 2013
  • by Global Markets Direct

This report provides data on the therapeutic development for Deep Vein Thrombosis (DVT), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...

Bone Cancer - Pipeline Review, H1 2013

Bone Cancer - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • March 2013
  • by Global Markets Direct

Bone Cancer - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Bone Cancer - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...

Pathology Industry: Squamous Cell Carcinom ...

April 2013 $ 2 000

Pathology Industry: Lung Cancer - Pipeline ...

April 2013 $ 2 000

World Drug And Medication: Bile Duct Cance ...

April 2013 $ 2 000

Kidney Cancer (renal Cell Cancer) - Pipeli ...

April 2013 $ 2 000

Cancer Research Technology Limited - Merge ...

March 2013 $ 350

Cancer Research Technology Limited Swot An ...

March 2013 $ 300

Ludwig Institute For Cancer Research Ltd S ...

March 2013 $ 300

More Reports:

Pathology in Argentina (8)
Pathology in Australia (39)
Pathology in Brazil (23)
Pathology in Canada (53)
Pathology in China (77)
Pathology in Egypt (5)
Pathology in France (135)
Pathology in Germany (137)
Pathology in Greece (7)

Related Market Segments :

Cancer
Cardiovascular Disease
Acute Coronary Syndrome
Stroke
Atrial Fibrillation

Company Profiles

10 Companies

Algeta ASA

Norway

Astellas Pharma Inc.

Japan

NCR Corp. (Beriut, Lebanon)

Lebanon

Teva Pharmaceutical Industries Ltd.

Israel

Roche Holding AG

Switzerland

Bayer AG

Germany

Medivation Inc.

United States

Roche Diagnostics Corp.

United States

Synta Pharmaceuticals Corp.

United States

Teva Pharmaceuticals

United States

Reportlinker.com © Copyright 2013. All rights reserved.

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.